BioNexus Gene Lab’s (BGLC) Board of Directors has formally approved the Company’s new Ethereum (ETH)-focused treasury strategy. Concurrently, BGLC has released its Ethereum Strategy Whitepaper ...

--BioNexus Gene Lab Corp., a technology company dedicated to innovation in technology and healthcare, is pleased to announce that its Board of Directors has formally approved the Company’ s new ...

BioNexus Gene Lab Corp (NASDAQ:BGLC) disclosed the immediate resignation of two board members, according to a recent 8-K filing with the Securities and Exchange Commission. On October 9, 2024, Mr ...

KUALA LUMPUR, Malaysia, July 24, 2023 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BioNexus” or the “Company”) (Nasdaq: BGLC), an emerging company in the business of selling chemical raw ...